🕒 Wednesday 24 June 2026 Wed, 24 June 2026
73 Articles
AFT Pharmaceuticals Eyes $300M Revenue with Global Expansion and R&D Milestones
AFT Pharmaceuticals delivered a 22% revenue jump in FY26 to NZD 254.7 million, surpassing profit guidance and expanding its footprint to 87 countries. The company is advancing multiple R&D projects, including a pivotal Phase III injectable iron trial, while targeting over NZD 300 million in revenue for FY27.
24 June
